auvi-q

Generic: auvi-q

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name auvi-q
Generic Name auvi-q
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

epinephrine .3 mg/.3mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1663
Product ID 51662-1663_23fdb616-0c61-44fe-e063-6394a90ad8f1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA201739
Listing Expiration 2026-12-31
Marketing Start 2012-11-15

Pharmacologic Class

Established (EPC)
alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc]
Mechanism of Action
adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]
Chemical Structure
catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621663
Hyphenated Format 51662-1663

Supplemental Identifiers

RxCUI
1870205
UNII
YKH834O4BH
NUI
N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name auvi-q (source: ndc)
Generic Name auvi-q (source: ndc)
Application Number NDA201739 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • .3 mg/.3mL
source: ndc
Packaging
  • 2 DOSE PACK in 1 CARTON (51662-1663-2) / .3 mL in 1 DOSE PACK (51662-1663-1)
source: ndc

Packages (1)

51662-1663-2 2 DOSE PACK in 1 CARTON (51662-1663-2) / .3 mL in 1 DOSE PACK (51662-1663-1)

Ingredients (1)

epinephrine (.3 mg/.3mL)

Linked Drug Pages (1)

AUVI-Q ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "23fdb616-0c61-44fe-e063-6394a90ad8f1", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "unii": ["YKH834O4BH"], "rxcui": ["1870205"], "spl_set_id": ["23fdb616-0c60-44fe-e063-6394a90ad8f1"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 DOSE PACK in 1 CARTON (51662-1663-2)  / .3 mL in 1 DOSE PACK (51662-1663-1)", "package_ndc": "51662-1663-2", "marketing_start_date": "20121115"}], "brand_name": "AUVI-Q", "product_id": "51662-1663_23fdb616-0c61-44fe-e063-6394a90ad8f1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Catecholamine [EPC]", "Catecholamines [CS]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1663", "generic_name": "AUVI-Q", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AUVI-Q", "active_ingredients": [{"name": "EPINEPHRINE", "strength": ".3 mg/.3mL"}], "application_number": "NDA201739", "marketing_category": "NDA", "marketing_start_date": "20121115", "listing_expiration_date": "20261231"}